ISSN:2167-7964

Journal of Radiology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Image Article   
  • OMICS J Radiol 2022, Vol 11(3): 374
  • DOI: 10.4172/2167-7964.1000374

Clinical Imaging-Lung Cancer Population Mortality

John Thomas*
Department of Radiology and Health science, Singapore
*Corresponding Author: John Thomas, Department of Radiology and Health science, Singapore, Email: John_T23@yahoo.com

Received: 08-Mar-2022 / Manuscript No. ROA-22-59283 / Editor assigned: 10-Mar-2022 / PreQC No. ROA-22-59283 (PQ) / Reviewed: 17-Mar-2022 / QC No. ROA-22-59283 / Revised: 23-Mar-2022 / Manuscript No. ROA-22-59283 (R) / Published Date: 30-Mar-2022 DOI: 10.4172/2167-7964.1000374

Image Article

Lung cancer (primary lung cancer), or frequently if somewhat incorrectly known as bronchogenic carcinoma, is an expansive term alluding to the fundamental histological subtypes of primary lung malignancies that are mainly linked with breathed in cancer-causing agents, with tobacco smoke being a key culprit.

Epidemiology

Lung cancer is a leading type of cancer, equivalent in predominance to breast cancer. It is the main source of cancer mortality around the world; representing 20% of cancer deaths [1].

Clinical presentation

Patients with lung cancer may be asymptomatic in up to 50% of cases. Hack and dyspnea are fairly vague side effects that are normal among those with lung cancer.

Central tumors may result in hemoptysis and peripheral lesions with pleuritic chest pain.

Pneumonia, pleural effusion, wheeze and lymphadenopathy are not uncommon. Different side effects may be secondary to metastases (bone, contralateral lung, brain, adrenal glands, and liver, in recurrence request for NSCLC 12) or paraneoplastic conditions (Figure 1).

radiology-Chest

Figure 1: Chest X-ray of Lung cancer.

Treatment and Prognosis

Treatment and prognosis differ with stage as well as with cell type. As a general rule, medical procedure, chemotherapy and radiotherapy are presented by the stage, resectability, operability, and functional status. Designated medicines rely upon molecular testing, e.g. ALK mutated lung cancers can be treated with ALK-inhibitors (e.g. crizotinib) [2].

References

  1. Rosado-de-Christenson ML, Templeton PA, Moran CA (1994) Bronchogenic Carcinoma: Radiologic-Pathologic Correlation. Radiographics 14: 429-446.
  2. Indexed at, Google Scholar, Crossref

  3. Le T, Gerber DE (2017) ALK Alterations and Inhibition in Lung Cancer. Semin Cancer Biol 42: 81-88.
  4. Indexed at, Google Scholar, Crossref

Citation: Thomas J (2022) Clinical Imaging- Lung Cancer Population Mortality. OMICS J Radiol 11: 374. DOI: 10.4172/2167-7964.1000374

Copyright: &Copy; 2022 Thomas J. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top